Amgen (AMGN) Tops Q2 EPS by 16c, Lifts FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
Go back to Amgen (AMGN) Tops Q2 EPS by 16c, Lifts FY Guidance
July 27, 2017 10:11 AM EDT
Argus raised its price target on Amgen (NASDAQ: AMGN) to $195.00 (from $180.00) while maintaining a Buy rating, following the company's second quarter earnings report.
Analyst David Toung notes the company delivered second quarter earnings per share and revenue results above consensus projections fueled by several... More
July 26, 2017 8:34 AM EDT
UBS raised its price target on Amgen (NASDAQ: AMGN) to $180.00 (from $175.00) while maintaining a Neutral rating. 2Q results were better than expectations with a $145M top-line beat. EPS also beat consensus estimates by $0.18.
UBS increased 2017 Enbrel sales estimates to $5.38B from $5B... More
July 26, 2017 6:18 AM EDT
Deutsche Bank raised its price target on Amgen (NASDAQ: AMGN) to $174.00 (from $172.00) while maintaining a Hold rating.
Analyst Andrew Peters called the quarter "solid" but said the near term outlook remains challenged.
"While the results beat expectations, we remain cautious on... More
